These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7160700)

  • 21. [Comparison of the polycardiographic changes induced with trinitrin and propranolol].
    Vitolo E; Bruno L; Cadel A; Bellinvia P
    Minerva Cardioangiol; 1970 Jul; 18(7):411-9. PubMed ID: 4994842
    [No Abstract]   [Full Text] [Related]  

  • 22. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
    Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
    Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propranolol in cardiac arrhythmias: a comparative study of the conventional and long-acting formulations.
    Kubik MM; Gill B; Dawes PM
    Curr Med Res Opin; 1986; 10(4):215-20. PubMed ID: 3780285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Log dose-response curve to assess the effects of propranolol in angina pectoris.
    Gillam PM; Prichard BN
    Br J Pharmacol; 1971 Feb; 41(2):408P. PubMed ID: 5572304
    [No Abstract]   [Full Text] [Related]  

  • 25. [The chronobiological aspects of drug resistance to antianginal therapy].
    Arushanian EB; Shamliian TA
    Eksp Klin Farmakol; 1994; 57(4):33-5. PubMed ID: 7950781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular arrhythmias associated with lidoflazine: side-effects observed in a randomized trial.
    Hanley SP; Hampton JR
    Eur Heart J; 1983 Dec; 4(12):889-93. PubMed ID: 6363079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta blockade and angina pectoris. A double-blind trial].
    Hvidt S
    Ugeskr Laeger; 1970 Jun; 132(23):1077-80. PubMed ID: 5419638
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of propranolol in angina pectoris and heart rhythm disorders].
    Serradimigni A; Bory M; Poggi L; Saadoun J; Bartoli A; Audier M
    Mars Med; 1968; 105(7):595-9. PubMed ID: 5697870
    [No Abstract]   [Full Text] [Related]  

  • 29. [Trial of a new long-acting antianginal agent].
    Saint-Pierre A
    Coeur Med Interne; 1973; 12(1):155-61. PubMed ID: 4580352
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeut effectiveness of alprenolol on angina pectoris.
    Toyama S; Suzuki K; Yamagami T; Amemiya T
    Naika Hokan; 1969 Aug; 16(8):351-8. PubMed ID: 5389048
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential index: a simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris.
    Bjorkander I; Forslund L; Kahan T; Ericson M; Held C; Rehnqvist N; Hjemdahl P
    Cardiology; 2008; 111(2):126-33. PubMed ID: 18376124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-acting propranolol (Inderal LA): pharmacokinetics, pharmacodynamics and therapeutic use.
    Mishriki AA; Weidler DJ
    Pharmacotherapy; 1983; 3(6):334-41. PubMed ID: 6361703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Verapamil or propranolol for the treatment of angina pectoris].
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Ugeskr Laeger; 1982 Jan; 144(4):240-3. PubMed ID: 7041382
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of long-acting propranolol on agonistic and stereotyped behaviors in a man with pervasive developmental disorder and fragile X syndrome: a double-blind, placebo-controlled study.
    Cohen IL; Tsiouris JA; Pfadt A
    J Clin Psychopharmacol; 1991 Dec; 11(6):398-9. PubMed ID: 1770165
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators.
    Glasser SP; Michie DD; Thadani U; Baiker WM
    Am J Cardiol; 1997 May; 79(10):1401-5. PubMed ID: 9165168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propranolol dose determinants including blood level studies.
    McLean CE; Deane BC
    Angiology; 1970 Sep; 21(8):536-45. PubMed ID: 5507354
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of diuretic therapy on exercise capacity in patients with chronic angina and preserved left ventricular function.
    Finimundi HC; Caramori PA; Parker JD
    J Cardiovasc Pharmacol; 2007 May; 49(5):275-9. PubMed ID: 17513945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronopharmacodynamics of betacap (long-acting propranolol) in patients with hypertension stage II].
    Zaslavskaia RM; Zhamankulov KA; Zhumabaeva TN; Teĭblium MM
    Klin Med (Mosk); 1998; 76(4):38-40. PubMed ID: 9613081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.